Table 3.
The results of genotyping of the groups.
| Group | rs2910164 miRNA-146a | rs138446575 TTC34 | rs1048943 CYP1A1 | rs55986091HLA-DQB1 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GG | GC | CC | CC | CT | TT | TT | TC | CC | GG | GA | AA | |
| Population control, n (%) | 82 (60) | 49 (36) | 6(4) | 132 (96) | 5(4) | 0 | 127 (93) | 10 (7) | 0 | 112(82) | 7(5) | 18 (13) |
| HPV-negative, n (%) | 135 (62) | 74 (34) | 9(4) | 208 (95) | 10 (5) | 0 | 202 (92.5) | 15 (7) | 1 (0.5) | 165 (76) | 16 (7) | 37 (17) |
| HPV-positive, n (%) | 78 (65) | 36 (30) | 6(5) | 116 (97) | 4(3) | 0 | 112 (93) | 7(6) | 1(1) | 101 (84) | 9(8) | 10(8) |
| CIN 2/3, n (%) | 116 (61) | 64 (34) | 11 (5) | 183 (96) | 8(4) | 0 | 174 (91) | 15 (8) | 2(1) | 166 (87) | 7(4) | 18(9) |
| CC, n (%) | 82 (66) | 36 (29) | 6(5) | 120 (97) | 4(3) | 0 | 114 (92) | 9(7) | 1(1) | 115 (93) | 5(4) | 4(3) |